SUNCHIP2 SYSTEM
Hyperthermic intraperitoneal and intrathoracic chemotherapy system
Performance in open and closed HIPEC / HITHOC for 20 years
- Description
- information
- benefits
- studies
- legal information
The SUNCHIP2 system is a medical device that complements surgical treatment with intraoperative chemotherapy by regulating temperature and flow in the abdominal or thoracic cavity.
This equipment enables a chemotherapy liquid to circulate in a closed circuit and heats it to a temperature and/or flow rate chosen by the surgeon. The chemotherapy liquid is circulated by 2 peristaltic pumps providing a high flow rate.
The SunChip2 works with SunChip 2 Set consumables for open techniques and SunChip 2 Set closed consumables for closed techniques.
Description
The SUNCHIP2 system is a medical device that complements surgical treatment with intraoperative chemotherapy by regulating temperature and flow in the abdominal or thoracic cavity.
This equipment enables a chemotherapy liquid to circulate in a closed circuit and heats it to a temperature and/or flow rate chosen by the surgeon. The chemotherapy liquid is circulated by 2 peristaltic pumps providing a high flow rate.
The SunChip2 works with SunChip 2 Set consumables for open techniques and SunChip 2 Set closed consumables for closed techniques.
Additional information
| Information | SunChip2 equipmentSunChip 2 setClosed SunChip 2 setDrainage kit |
|---|---|
| Benefits | Techniques: open and closedTwo peristaltic pumps with adjustable flow rates from 300 to 1300 ml/min per pumpTwo high-performance heat exchangers for temperatures up to 48°CTarget temperature reached in less than 10 minutesUse of precise single-use temperature probesFlow direction can be reversed without additional accessoriesPressure measurement for closed techniquesData transfer via USBLarge touch screenVisual and audible alarms |
| Studies | Hyperthermic intraperitoneal chemotherapy in platinum-sensitive relapsed epithelial ovarian cancer: The CHIPOR randomized phase III trial. JM Classe et al.2023 ASCO Annual Meeting,J Clin Oncol 41,2023(suppl16;abstr 5510).Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. Van Driel WJ et al. N Engl J Med. 2018 Jan 18;378(3):230-240.Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy(HIPEC)procedure. Armande Konate,Joel Poupon,Antoine Villa,Robert Garnier,Hélène Hasni-Pichard,Danielle Mezzaroba,Gabriel Fernandez and Marc Pocard. JSO 2011;103:6-89Optimization of Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin Plus Irinotecan at 43°C After Complete Cytoreductive Surgery: Mortality and Morbidity in 106 Consecutive Patients. Elias D.,Goere D.,Blot,F.,Billard V.,Pocard M.,Kohneh-Shahri N.,Raynard B. Ann Surg Oncol. 2007;14:1818-1824.Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement. J. Esquivel and al,Ann. Surg. Oncol. 2007;14:128-133.Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal Carcinoma. Yan,T. D.,Black,D.,Savady,R.,Sugarbaker,P. H. J Clin Oncol. 2006;24:4011-4019.Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer. Verwaal V. J.,van Ruth S.,de Bree E.,van Slooten G. W.,van Tinteren H.,Boot H.,Zoetmulder F. A.N. JCO. 2003;21:3737-3743.Toward Curative Treatment of Peritoneal Carcinomatosis from Nonovarian Origin by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy. Olivier Glehen,François Gilly,Florent Boutitie,Jean-Marc Bereder,François Quenet,Lucas Sideris,Baudouin Mansvelt,Gérard Lorimier,Simon Msika,Dominique Elias,and French Surgical Association. Cancer December 15,2001 |
| Legal information | SunChip 2 intra-peritoneal and intra-thoracic hyperthermic chemotherapy system. Class IIb medical device. CE0051. Certification body: IMQ. Manufactured by GamidaTECH. Not included in the list of reimbursable products and services provided for in article L165-1 of the French Social Security Code. Read the instructions carefully before use. |
| Fabricant | |
| Traduction_FR | 5109 |
